Breaking News

Has no content to show!

Pharmaceutical News

Dr Reddy’s Visakhapatnam unit not cleared by USFDA even after EIR

Dr Reddy’s Laboratories Ltd said on Tuesday that the US Food and Drug Administration (FDA) has issued a procedural Establishment Inspection Report (EIR) to its cancer drugs facility at Duvvada in Visakhapatnam following the plant audit in March this year but the inspection has not been closed and warning letter on the unit stays.


Faulty hip implants: Johnson & Johnson may have to pay each patient Rs20 lakh

Johnson and Johnson may be ordered to pay at least Rs20 lakh in compensation to each of the 22 Indian patients who were given allegedly faulty hip implants that required them to undergo revision surgeries, according to two people with knowledge of the matter.


US FDA warns Lupin on repeated quality violation

Lupin Ltd, which makes generic antibiotics, antidepressants and heart medications for sale in the US, was warned by the US Food and Drug Administration (FDA)


Zydus Cadila, Intas under scanner for launching hypertension drug without permit

Two domestic drug makers are under the scanner of the pharmaceutical regulator for allegedly launching a combination drug to treat hypertension without mandatory prior approval.


About Us

Wealthbuilder.co.in is design and developed to provide quality trading and investment recommendations & guidance for trading in the Indian Stock Market.

Wealthbuilder.co.in attempts to deliver a value driven service to the investing community by bringing together a powerful mix of expert advice, stock news and analysis.

Contact Information


Brand Partners